Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,898 | 183 | 90.1% |
| Education | $426.91 | 6 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $750.51 | 69 | $0 (2024) |
| ABBVIE INC. | $723.05 | 27 | $0 (2024) |
| Celgene Corporation | $506.03 | 6 | $0 (2019) |
| Janssen Biotech, Inc. | $436.13 | 14 | $0 (2024) |
| GENZYME CORPORATION | $303.07 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $293.33 | 18 | $0 (2024) |
| Lilly USA, LLC | $292.95 | 13 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $217.71 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $215.81 | 3 | $0 (2019) |
| PFIZER INC. | $122.12 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.71 | 11 | SUN PHARMACEUTICAL INDUSTRIES INC. ($72.00) |
| 2023 | $545.80 | 28 | E.R. Squibb & Sons, L.L.C. ($225.26) |
| 2022 | $606.91 | 45 | Novartis Pharmaceuticals Corporation ($268.23) |
| 2021 | $1,090 | 72 | Novartis Pharmaceuticals Corporation ($421.74) |
| 2019 | $950.16 | 17 | AbbVie, Inc. ($413.50) |
| 2018 | $832.64 | 14 | Celgene Corporation ($257.42) |
| 2017 | $41.45 | 2 | LEO Pharma Inc. ($41.45) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Immunology | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology | ||||||
| 05/28/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: DERMATOLOGY | ||||||
| 04/29/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Immunology | ||||||
| 04/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Immunology | ||||||
| 03/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Dermatology | ||||||
| 01/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $72.00 | General |
| 01/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Immunology | ||||||
| 12/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 12/19/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Immunology | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.66 | General |
| Category: Immunology | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.82 | General |
| Category: Immunology | ||||||
| 11/27/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Immunology | ||||||
| 11/27/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 09/26/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $115.52 | General |
| Category: Immunology | ||||||
| 09/25/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.82 | General |
| Category: Immunology | ||||||
| 09/21/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Immunology | ||||||
| 09/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| Category: Immunology | ||||||
| 07/03/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Dermatology | ||||||
| 06/21/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Immunology | ||||||
| 06/14/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,745 | 3,172 | $584,508 | $202,298 |
| 2022 | 25 | 1,626 | 2,801 | $521,259 | $165,491 |
| 2021 | 25 | 1,960 | 3,624 | $616,719 | $202,312 |
| 2020 | 3 | 34 | 88 | $5,810 | $1,496 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 121 | 140 | $182,000 | $68,767 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 480 | $82,784 | $28,940 | 35.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 40 | 57 | $44,831 | $17,967 | 40.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 49 | 52 | $30,836 | $11,848 | 38.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 160 | 181 | $35,929 | $11,021 | 30.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 150 | $32,475 | $11,002 | 33.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 207 | 272 | $34,544 | $10,025 | 29.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 123 | 123 | $26,160 | $8,520 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 110 | 153 | $16,290 | $6,102 | 37.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 159 | 1,050 | $13,125 | $4,826 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 40 | $9,710 | $3,768 | 38.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 14 | $8,414 | $3,104 | 36.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 19 | 19 | $11,619 | $2,560 | 22.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 26 | $12,415 | $2,450 | 19.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 19 | 20 | $10,890 | $2,157 | 19.8% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 11 | 11 | $6,028 | $1,841 | 30.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 14 | $4,445 | $1,580 | 35.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 33 | 41 | $4,162 | $1,489 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,803 | $1,426 | 37.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 30 | 30 | $4,110 | $1,069 | 26.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 22 | $2,387 | $680.04 | 28.5% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $2,477 | $631.03 | 25.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 36 | $3,996 | $350.23 | 8.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 216 | $1,080 | $172.85 | 16.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 87 | 117 | $152,100 | $52,651 | 34.6% |
About Dr. Gregory Messenger, MD
Dr. Gregory Messenger, MD is a Dermatology healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821441486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Messenger, MD has received a total of $4,325 in payments from pharmaceutical and medical device companies, with $257.71 received in 2024. These payments were reported across 189 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,898).
As a Medicare-enrolled provider, Messenger has provided services to 5,365 Medicare beneficiaries, totaling 9,685 services with total Medicare billing of $571,597. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Clinical & Laboratory Dermatological Immunology
- Location Lansing, MI
- Active Since 07/19/2016
- Last Updated 07/16/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821441486
Products in Payments
- COSENTYX (Biological) $689.97
- Otezla (Drug) $506.03
- Humira (Biological) $344.75
- Sotyktu (Drug) $276.39
- TALTZ (Drug) $275.49
- DUPIXENT (Drug) $238.25
- DUPIXENT DUPILUMAB INJECTION (Biological) $205.00
- REMICADE (Biological) $182.27
- DUPIXENT (Biological) $155.62
- TREMFYA (Drug) $153.87
- Skyrizi (Biological) $132.83
- EUCRISA (Drug) $122.12
- HUMIRA (Biological) $115.12
- SKYRIZI (Biological) $106.12
- Tremfya (Drug) $99.99
- SILIQ (Drug) $99.54
- ENSTILAR (Drug) $67.90
- Cimzia (Drug) $65.71
- COSENTYX (Drug) $60.54
- ILUMYA (Biological) $59.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lansing
Yuelin Xu, M.d, M.D
Dermatology — Payments: $11,564
Gregory Messenger, M.d, M.D
Dermatology — Payments: $3,287
Dr. Ronald Miller, D.o, D.O
Dermatology — Payments: $1,050
Katherine English, D.o, D.O
Dermatology — Payments: $776.36
Dr. Mark Hatch, D.o, D.O
Dermatology — Payments: $364.24
Dr. William Heckert, D.o, D.O
Dermatology — Payments: $73.37